NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
August 31, 2024 — Harper Ellsworth Advertising and Texas Radiotherapy recognized as finalists for the 2024 MM+M Awards, showcasing outstanding work in healthcare marketing and raising awareness about prostate cancer.
August 29, 2024 — Clene's CNM-Au8 trials for ALS and MS treatment show promise for improving patient outcomes. The innovative approach could have a significant impact on the therapeutic market.
August 29, 2024 — Syntekabio introduces 'Develop Now, Pay Later' offer to minimize risk, save time and costs, and increase the success rate of companies developing novel therapies.
August 29, 2024 — Monogram Orthopedics prepares to launch its next-gen surgical robot, positioning itself to capitalize on the growing orthopedic surgery robotic market. Surgeons discuss the impact of the company's technology on patient care and outcomes.
August 29, 2024 — Nuvectis Pharma has achieved a significant milestone with the FDA granting Orphan Drug Designation for NXP800, a potential game-changer in oncology. This news highlights the urgent need for innovative treatments in rare cancers, offering hope for patients and strategic benefits for the company.
August 29, 2024 — Aclarion expands CLUE Trial to New Jersey with Dr. Justin Kubeck joining the network of surgeons. The trial aims to identify how often Nociscan's AI data changes the initial treatment plan for patients with chronic low back pain.
August 29, 2024 — SaveRxCanada.to announces free shipping on all orders through its International Generics Program, making affordable medications even more accessible for customers. The initiative highlights the value of generic medications, offering up to 85% savings compared to brand-name versions.
August 29, 2024 — Read the inspiring story of Eliezer and Tzirel Miller's journey through their daughter's lymphatic malformation diagnosis. Discover hope, resilience, and unwavering faith in the face of adversity.
August 29, 2024 — GeoVax Labs, Inc. announces a securities purchase agreement with an institutional investor, securing funding for the development of immunotherapies and vaccines against cancer and infectious diseases.
August 28, 2024 — iCoreConnect Inc. partners with Alaska Dental Society and endorses nine products, expanding its presence and driving efficiency in dental practices. The endorsement provides lead generation opportunities and an effective distribution channel for iCoreConnect.
August 28, 2024 — Monogram Technologies (NASDAQ: MGRM) forms strategic partnership with Shalby Limited for robotic orthopedic surgery clinical trial, signaling a major advancement in the industry and potential future collaborations.
August 28, 2024 — Statistics Canada data reveals that 45% of Canadians are struggling with rising prices, impacting their day-to-day expenses and mental health. This news sheds light on the widespread impact and highlights the need for solutions.
August 28, 2024 — SaveRxCanada.to celebrates 20 years of providing affordable prescription medications, connecting American consumers with licensed Canadian pharmacies.
August 28, 2024 — Alfa Cytology unveils new services for developing oncolytic viral therapy for pancreatic cancer, showcasing the enormous potential of targeted therapy methods and the focus on enhancing the immune system's ability to fight against cancer.
August 28, 2024 — PathAI's AISight Dx Image Management System is In Vitro Diagnostic Regulation (IVDR) certified for use in primary diagnosis, paving the way for European market expansion and improving diagnostic accuracy and patient outcomes.
August 28, 2024 — Cherished Mom launches IsMomOK.org, a platform addressing maternal suicide and mortality, offering support and resources for pregnant and postpartum women, and aiming to reduce stigma and save lives.
August 28, 2024 — ADAP Advocacy unveils limited edition 'Light for Hope' candle for World AIDS Day 2024, designed by MoonAmor Candle Co. The candle embodies solidarity in the fight to end the HIV/AIDS epidemic and remembers those lost to it. CEO Brandon M. Macsata and MoonAmor Candle Co. Founder Noritza Perito shared the significance, urging supporters to light them on December 1st at 7:00 p.m. ET.
August 28, 2024 — AGC Biologics achieves FDA approval for biosimilar in Copenhagen, marking a significant milestone for the company and the biosimilar market. With the expected market value for biosimilars to reach over $126 billion by 2032, this achievement demonstrates the company's commitment to providing high-quality, cost-effective treatment options for patients in need.
August 27, 2024 — Lexaria Bioscience releases groundbreaking research findings on DehydraTECH(TM) technology and GLP-1 drug
August 27, 2024 — Annovis Bio (NYSE: ANVS) reports positive Q2 results for lead compound, showing promise for neurodegenerative disease treatment.